Login / Signup

Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.

Khaled Ibrahim AlatibiStefan TholenZeinab WehbeJudith HagenbuchnerDaniela KarallMichael J AusserlechnerOliver SchillingSarah Catharina GrünertJerry VockleySara Tucci
Published in: International journal of molecular sciences (2021)
Medium-chain fatty acids (mc-FAs) are currently applied in the treatment of long-chain fatty acid oxidation disorders (lc-FAOD) characterized by impaired β-oxidation. Here, we performed lipidomic and proteomic analysis in fibroblasts from patients with very long-chain acyl-CoA dehydrogenase (VLCADD) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHADD) deficiencies after incubation with heptanoate (C7) and octanoate (C8). Defects of β-oxidation induced striking proteomic alterations, whereas the effect of treatment with mc-FAs was minor. However, mc-FAs induced a remodeling of complex lipids. Especially C7 appeared to act protectively by restoring sphingolipid biosynthesis flux and improving the observed dysregulation of protein homeostasis in LCHADD under control conditions.
Keyphrases
  • fatty acid
  • hydrogen peroxide
  • high glucose
  • diabetic rats
  • combination therapy
  • electron transfer
  • oxidative stress
  • visible light
  • replacement therapy
  • liquid chromatography
  • binding protein